APA (7th ed.) Citation

Possemis, N., Verhey, F., Prickaerts, J., Blokland, A., & Ramakers, I. (2024). A proof of concept phase II study with the PDE-4 inhibitor roflumilast in patients with mild cognitive impairment or mild Alzheimer’s disease dementia (ROMEMA): Study protocol of a double-blind, randomized, placebo-controlled, between-subjects trial. Current controlled trials in cardiovascular medicine, 25(1), 162-20. https://doi.org/10.1186/s13063-024-08001-3

Chicago Style (17th ed.) Citation

Possemis, Nina, Frans Verhey, Jos Prickaerts, Arjan Blokland, and Inez Ramakers. "A Proof of Concept Phase II Study with the PDE-4 Inhibitor Roflumilast in Patients with Mild Cognitive Impairment or Mild Alzheimer’s Disease Dementia (ROMEMA): Study Protocol of a Double-blind, Randomized, Placebo-controlled, Between-subjects Trial." Current Controlled Trials in Cardiovascular Medicine 25, no. 1 (2024): 162-20. https://doi.org/10.1186/s13063-024-08001-3.

MLA (9th ed.) Citation

Possemis, Nina, et al. "A Proof of Concept Phase II Study with the PDE-4 Inhibitor Roflumilast in Patients with Mild Cognitive Impairment or Mild Alzheimer’s Disease Dementia (ROMEMA): Study Protocol of a Double-blind, Randomized, Placebo-controlled, Between-subjects Trial." Current Controlled Trials in Cardiovascular Medicine, vol. 25, no. 1, 2024, pp. 162-20, https://doi.org/10.1186/s13063-024-08001-3.